Related Experiment Video
Updated: Jul 14, 2026

Rapid and Specific Immunomagnetic Isolation of Mouse Primary Oligodendrocytes
Published on: May 21, 2018
Negative correlation of Nogo-A with the malignancy of oligodendroglial tumor
Nan-Xiang Xiong1, Hong-Yang Zhao, Fang-Cheng Zhang
1Department of Neurosurgery, Xiehe Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.
Objective:
Nogo-A is an axon regeneration inhibitor, and its function in central nervous system (CNS) is still unknown. The present study is to explore the relationship between the expression of Nogo-A and the malignancy of oligodendroglial tumors in patients.
Methods:
Tumor tissue samples with different malignancy grade were obtained from the hospitals. The samples used for detection had been diagnosed as oligodendroglial tumors (oligodendroglioma or anaplastic oligodendroglioma). The expression of Nogo-A was detected by immunohistochemistry and western-blot analysis. The correlation test between the Nogo-A expression and the morphological changes (the percentages of atypical cells and mitotic cells in the tumors) related to the malignancy of tumor tissues was performed.
Results:
There was significant negative correlation between the Nogo-A expression and the morphological change of tumor tissues according to immunohistochemistry. Western-blot analysis also indicated that the gray value of Nogo-A protein band in the oligodendroglioma group was significantly higher than that in the anaplastic oligodendroglioma group.
Conclusion:
Nogo-A expression was negatively correlated with the malignancy grade of oligodendroglial tumors.
Insights
Nogo-A expression is linked to lower oligodendroglial tumor malignancy. Higher Nogo-A levels correlate with less aggressive tumors, suggesting a potential role in tumor suppression.
Area of Science:
- Neuroscience
- Oncology
- Molecular Biology
Background:
- Nogo-A is an inhibitor of axon regeneration in the central nervous system (CNS).
- The specific role of Nogo-A in CNS tumors, particularly oligodendroglial tumors, remains largely uncharacterized.
- Understanding Nogo-A's function could reveal new therapeutic targets for brain tumors.
Purpose of the Study:
- To investigate the relationship between Nogo-A expression and the malignancy grade of oligodendroglial tumors.
- To determine if Nogo-A levels correlate with specific morphological features indicative of tumor aggressiveness.
Main Methods:
- Immunohistochemistry and Western blot analysis were used to detect Nogo-A expression in oligodendroglial tumor samples.
- Tumor tissues, including oligodendroglioma and anaplastic oligodendroglioma, were analyzed.
- Correlation tests were performed between Nogo-A expression and tumor morphological changes (atypical cell percentage, mitotic index).
Main Results:
- A significant negative correlation was observed between Nogo-A expression and tumor tissue morphological changes.
- Immunohistochemistry indicated lower Nogo-A expression in more malignant tumors.
- Western blot analysis revealed significantly higher Nogo-A protein levels in oligodendroglioma compared to anaplastic oligodendroglioma.
Conclusions:
- Nogo-A expression is negatively correlated with the malignancy grade of oligodendroglial tumors.
- Reduced Nogo-A expression is associated with increased tumor aggressiveness.
- These findings suggest Nogo-A may play a role in suppressing oligodendroglial tumor progression.
Related Concept Videos
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
